REDUCED PREDNISOLONE BIOAVAILABILITY DURING RIFAMPICIN TREATMENT

被引:0
|
作者
BERGREM, H [1 ]
REFVEM, OK [1 ]
机构
[1] NATL UNIV HOSP OSLO,RIKSHOSP,MED DEPT B,OSLO,NORWAY
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:551 / 551
页数:1
相关论文
共 50 条
  • [41] RIFAMPICIN-DEPENDENT ANTIBODIES DURING INTERMITTENT TREATMENT
    VIRGILIO, R
    SCANDINAVIAN JOURNAL OF RESPIRATORY DISEASES, 1973, : 83 - 86
  • [42] Liver Injury During Treatment With Rifampicin, Vancomycin, and Acetaminophen
    Khanal, Subrat
    Ghimire, Pranita
    Dhamoon, Amit S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (06) : E735 - E737
  • [43] CHANGES IN SERUM AND URINARY CONCENTRATION OF RIFAMPICIN DURING TREATMENT
    PECHERE, JC
    TANCREDE, C
    PATHOLOGIE BIOLOGIE, 1969, 17 (3-4): : 155 - &
  • [45] BIOAVAILABILITY OF REDUCED IRON
    PLA, GW
    FRITZ, JC
    HARRISON, BN
    FEDERATION PROCEEDINGS, 1972, 31 (02) : A711 - &
  • [46] BIOAVAILABILITY AND DISPOSITION OF PREDNISONE AND PREDNISOLONE FROM PREDNISONE TABLETS
    ROSE, JQ
    YURCHAK, AM
    JUSKO, WJ
    POWELL, D
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1980, 1 (05) : 247 - 258
  • [47] PREDNISONE AND PREDNISOLONE BIOAVAILABILITY IN RENAL-TRANSPLANT PATIENTS
    GAMBERTOGLIO, JG
    FREY, FJ
    HOLFORD, NHG
    BIRNBAUM, JL
    LIZAK, PS
    VINCENTI, F
    FEDUSKA, NJ
    SALVATIERRA, O
    AMEND, WJC
    KIDNEY INTERNATIONAL, 1982, 21 (04) : 621 - 626
  • [48] SEROLOGIC STUDIES ON OCCURRENCE OF SPECIFIC RIFAMPICIN ANTIBODIES DURING CONTINUOUS RIFAMPICIN TREATMENT - ITS FREQUENCY AND SIGNIFICANCE
    KROPP, R
    KRUPE, M
    JUNGBLUTH, H
    PNEUMONOLOGIE-PNEUMONOLOGY, 1976, 153 (02): : 109 - 117
  • [49] Coagulation disorders during treatment with cefazolin and rifampicin: rarebut dangerous
    Kouki, Ines
    Montagner, Clemence
    Mauhin, Wladimir
    London, Jonathan
    Lazard, Thierry
    Grimbert, Sylvie
    Zeller, Valerie
    Lidove, Olivier
    JOURNAL OF BONE AND JOINT INFECTION, 2021, 6 (05) : 131 - 134